Paul Enever

Paul Enever is a seasoned professional in healthcare growth equity and late-stage venture capital, currently serving as a Partner at Evidity Health Capital since January 2014. Enever leads the healthcare platform, focusing on investments in private companies within the med-tech, diagnostics, and digital health sectors. Additionally, Enever holds board positions at multiple companies, including Augmedics, Poseidon Medical, Inc., Standard Molecular, Inc., Magnolia Medical Technologies, and has previously served on the boards of Cardiva Medical and Dune Medical Devices. Prior to joining Evidity, Enever was a Principal at McKinsey & Company, where leadership in consulting for medical device, pharmaceutical, and healthcare clients was demonstrated. Enever earned a PhD in Chemical Engineering from the University of Minnesota and a BS in Chemical Engineering from Rensselaer Polytechnic Institute.